Wilmot Cancer Institute

Font Size:

  • The Institute continued to make advances in immunotherapy, where progress is accelerating in engaging the immune system to fight cancer. Wilmot researchers are contributing to those advances, learning more about the role of immune cells in cancer, studying promising new therapies and developing novel ways to improve immunotherapy.
  • The Blood and Marrow Transplant Program performed its 3,000th transplant. Nearly a dozen new clinical trials were opened for gynecologic cancers.
  • Investigators from the Institute presented their findings at major national meetings held by the American Society of Clinical Oncology and the American Society of Hematology. Their studies included addressing side effects of treatment with exercise, new biomarkers for bile duct cancers, and improving treatment for chronic lymphocytic leukemia, among other findings.

Bullet points highlight impact made in 2016